Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Kovac

Urology Carmel, IN Medical Doctor

NPI 1033462239 CMS profile 228169

11405 Pennsylvania St Ste 104, Carmel, IN 46032

Open in the dashboard

General payments

$111,950

373 records reported · program years 2019–2025

Research payments

$1,323

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$136,454 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Jason Kovac of Carmel, IN is reported in the CMS Open Payments database as having received $111,950 across 373 general payments and $1,323 in research payments paid to them. Separately, studies naming them as principal investigator received $136,454 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $111 6
2024 General $250 13
2023 General $18,746 31
2022 General $46,303 81
2021 General $27,574 111
2020 General $14,516 31
2019 General $4,449 100
2019 Research $1,323 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Kovac
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Jason Kovac were reported at $111. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Jason Kovac Urology median Middle half National median
2019 $4,449 $480 $147–$1,201 $163
2020 $14,516 $246 $87–$645 $114
2021 $27,574 $358 $111–$1,000 $132
2022 $46,303 $476 $143–$1,263 $149
2023 $18,746 $560 $168–$1,461 $160
2024 $250 $563 $170–$1,464 $164
2025 $111 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Antares Pharma, Inc. $64,317 116 payments
  2. Clarus Therapeutics Inc. $31,159 66 payments
  3. Acerus Pharmaceuticals Corporation $9,194 17 payments
  4. Boston Scientific Corporation $2,636 32 payments
  5. Aytu BioScience, Inc $1,794 5 payments
  6. Coloplast Corp $643 12 payments
  7. Endo Pharmaceuticals Inc. $434 19 payments
  8. Endo USA, Inc. $234 12 payments
  9. Genzyme Corporation $226 12 payments
  10. Halozyme Inc $209 7 payments
  11. Other $1,101 75 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $68,525 38 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,916 12 payments
  3. Travel and Lodging $11,205 48 payments
  4. Food and Beverage $7,303 275 payments
Products named General payments · program years 2019–2025
  1. TLANDO $62,360 68 payments
  2. XYOSTED $44,085 66 payments
  3. JATENZO testosterone replacement therapy $31,159 66 payments
  4. JATENZO testosterone replacement therapy $31,159 66 payments
  5. JATENZO testosterone replacement therapy $31,159 66 payments
  6. Natesto Urology Endocrinology Men's Health $9,194 17 payments
  7. Natesto Urology $1,794 5 payments
  8. AMS $1,557 23 payments
  9. AMS 700 CXR RTE KIT $800 1 payment
  10. XIAFLEX $606 28 payments
  11. Other $4,268 232 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $1,323 11 payments

Records

384 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record